Phaseline

Targets › IFNA

IFNA: drug programs, companies and trials

1 program from 1 company in 1 trial: 1 Phase 4; Infectious disease.

Open in Phaseline: the race on IFNA, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
Third Affiliated Hospital, Sun Yat-Sen Universitypegylated interferon-alfa
Type I interferon receptor agonist with antiviral and immunomodulatory properties for hepa
IFNAPhase 4Hepatitis B, Chronic–

Conditions

Hepatitis B, Chronic (1)

Modalities

protein or peptide (1)

Companies

Third Affiliated Hospital, Sun Yat-Sen University (1)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.